David Mitchell, PharmD, MBA, UC Davis, shares how collaboration between health systems and manufacturers is transforming patient access and outcomes for rare disease treatments.
David Mitchell, PharmD, MBA
Advertisement
David Mitchell, PharmD, MBA, senior pharmacist manager, assistant clinical professor, UC Davis.
Articles by David Mitchell, PharmD, MBA
How Health Systems, Pharmacy Teams Tackle Rare Disease Therapy Barriers: David Mitchell, PharmD, MBA
David Mitchell, PharmD, MBA, senior pharmacist manager and assistant clinical professor at UC Davis, addresses how health systems are overcoming financial, operational, and access challenges for patients with rare diseases.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
How Often Do Health Insurers Deny Doctor-Recommended Care?
2
Sudden Death in HFpEF Often Preceded by Clinical Decline
3
New Data Support Pimicotinib as Durable for Rare Tenosynovial Giant Cell Tumor
4
What Managed Care Should Watch at ADA 2026 Scientific Sessions
5